Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants With Dementia Due to Alzheimer's Disease
The purpose of this study is to assess the efficacy of the oral medication IGC-AD1, a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a…
Alzheimer DiseaseAgitation,PsychomotorCare Giving Burden+2 more
IGC Pharma, LLCNCT05543681
Observational
Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia
This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia includi…
Alzheimer DementiaAgitation,Psychomotor
Brent ForesterNCT03926520